MLchartDataset catalogue

Copper Cu 64 trastuzumab

Term · Oncology and biomedicine · MLC-T-ONC-012753

A diagnostic radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody trastuzumab conjugated with the positron-emitting radioisotope copper Cu 64. Copper Cu 64 trastuzumab binds to the extracellular domain of human epidermal growth factor receptor 2 (HER2), allowing the detection of HER2 distribution using positron emission tomography (PET).

Table 1. Record
IdentifierMLC-T-ONC-012753
FieldOncology and biomedicine
SynonymsCu-64-trastuzumab
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-012753",
  "term": "Copper Cu 64 trastuzumab",
  "field": "Oncology and biomedicine",
  "definition": "A diagnostic radioimmunoconjugate comprised of the recombinant humanized monoclonal antibody trastuzumab conjugated with the positron-emitting radioisotope copper Cu 64. Copper Cu 64 trastuzumab binds to the extracellular domain of human epidermal growth factor receptor 2 (HER2), allowing the detection of HER2 distribution using positron emission tomography (PET).",
  "synonyms": [
    "Cu-64-trastuzumab"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/copper-cu-64-trastuzumab/"
}

Record 5,302 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.